CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach.
Depression is very common in Parkinson's disease (PD) and linked with a faster progression of physical symptoms, greater cognitive decline and poorer quality of life. Nonpharmacological approaches, such as cognitive-behavioral therapy (CBT), for the treatment of depression in PD (dPD) have received little experimental attention despite strong demonstrated efficacy in other geriatric and medical populations. Depressed PD patients often differ from the depressed non-PD elderly in that they present with increased rates of both executive dysfunction and comorbid psychiatric diagnoses, may differ in their depressive symptom presentation and typically have caregivers who are highly involved in their treatment. Therefore, it is not possible to conclude that empirically validated treatments in the depressed aged will generalize to those with PD. In order to be most effective for PD patients, CBT should be tailored to their unique needs. Additional controlled research is needed to further explore the efficacy of CBT for dPD.
Dobkin
Roseanne DeFronzo
RD
Department of Psychiatry, UMDNJ/Robert Wood Johnson Medical School, 675 Hoes Lane, Room D-317, Piscataway, NJ 08854, USA. dobkinro@umdnj.edu
Menza
Matthew
M
Bienfait
Karina L
KL
D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003863:Depression / Q000209:etiology* / Q000523:psychology / Q000628:therapy*; D005104:Expert Testimony; D006801:Humans; D010300:Parkinson Disease / Q000150:complications* / Q000523:psychology; D011788:Quality of Life; D012944:Social Support